Trial Outcomes & Findings for Advanced MRI Sequences for Radiation Therapy Treatment Planning (NCT NCT02340715)
NCT ID: NCT02340715
Last Updated: 2017-10-31
Results Overview
We tested these Advanced MR protocols to evaluate which ones would best visualize the target region. This helped us determine the optimum MR SIM protocols for different sites that became clinical standard.
COMPLETED
158 participants
up to 4 weeks from imaging
2017-10-31
Participant Flow
420 was the initial estimate but 158 subjects was the accrual
158 subjects were enrolled.
Participant milestones
| Measure |
MRI for Treatment Planning or Follow up
MRI for treatment planning for radiation therapy or those who have completed treatment and are receiving follow up care.
|
|---|---|
|
Overall Study
STARTED
|
158
|
|
Overall Study
COMPLETED
|
158
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Advanced MRI Sequences for Radiation Therapy Treatment Planning
Baseline characteristics by cohort
| Measure |
MRI for Treatment Planning or Follow up
n=158 Participants
MRI for treatment planning for radiation therapy or those who have completed treatment and are receiving follow up care.
|
|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
114 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
44 Participants
n=5 Participants
|
|
Sex: Female, Male
Female
|
85 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
73 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: up to 4 weeks from imagingWe tested these Advanced MR protocols to evaluate which ones would best visualize the target region. This helped us determine the optimum MR SIM protocols for different sites that became clinical standard.
Outcome measures
| Measure |
MRI for Treatment Planning or Follow up
n=158 Participants
Patients aged 18 years and older of any race or gender with brain, head and neck, breast, lung, cervix, sarcoma, pancreatic, or prostate cancer undergoing MRI scans for radiation treatment planning and/or treatment follow-up at FMLH.
|
|---|---|
|
Number of Participants Successfully Contributing MRI Data
|
158 Participants
|
Adverse Events
MRI for Treatment Planning or Follow up
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place